36. Safety and Reactogenicity of the Adjuvanted Recombinant Zoster Vaccine after Allogeneic Hematopoietic Stem Cell Transplantation

BACKGROUND: Herpes zoster (HZ) is common after allogeneic hematopoietic stem cell transplantation (HCT) and associated with high morbidity. While antiviral prophylaxis reduces incidence, increased risk remains after discontinuation and vaccination strategies are needed. A non-live adjuvanted recombi...

Descripción completa

Detalles Bibliográficos
Autores principales: Baumrin, Emily, Izaguirre, Natalie E, Bausk, Bruce P, Feeley, Monica M, Bay, Camden P, Ho, Vincent T, Issa, Nicolas C, Baden, Lindsey R
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2020
Materias:
Poster Abstracts
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7776116/
http://dx.doi.org/10.1093/ofid/ofaa439.081

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7776116/
http://dx.doi.org/10.1093/ofid/ofaa439.081

Ejemplares similares